FDA Inspection 982746 — JICE Pharmaceuticals Company

JICE Pharmaceuticals Company — FEI 1833189

The FDA completed an inspection of JICE Pharmaceuticals Company on July 26, 2016 in Belding, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2016
Fiscal Year
2016
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Belding, MI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
188321 CFR 211.165(a)Testing and release for distribution
192021 CFR 211.166(a)(3)Valid stability test methods
431421 CFR 211.84(d)(2)Reports of Analysis (Components)